In addition, in some tumor cells, the mRNA precursor of NRF2 can undergo alternative splicing, resulting in loss of the domain interacting with Keap1, so that Keap1 fails to bind to NRF2 normally, leading to NRF2 stabilization and a decrease in ferroptosis in cancer cells [78]. Here, KEAP1 is linked to cancer.